SCHEMBL469761

SCHEMBL469761

CCCCOC[C@H]1OC(C)[C@H](OCCCC)[C@@H](OCCCC)[C@@H]1OCCCC

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ GJB2 P29033 4/20 0.40
▸ SSTR1 P30872 1/20 0.36
▸ SSTR2 P30874 1/20 0.36
▸ SSTR4 P31391 1/20 0.36
▸ SSTR3 P32745 1/20 0.36
▸ SSTR5 P35346 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ GBA1 P04062 1/20 0.33
▸ FGF1 P05230 3/20 0.32
▸ FGF2 P09038 3/20 0.32
▸ VEGFA P15692 3/20 0.32
▸ HPSE Q9Y251 3/20 0.32
▸ TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15255412 1.00 SMN1; SMN2 (0.41) SMN1; SMN2GJB2SSTR1SSTR2SSTR4
SCHEMBL12556188 1.00 SMN1; SMN2 (0.41) SMN1; SMN2GJB2SSTR1SSTR2SSTR4
SCHEMBL14392184 1.00 SMN1; SMN2 (0.41) SMN1; SMN2GJB2SSTR1SSTR2SSTR4
SCHEMBL15883987 1.00 SMN1; SMN2 (0.41) SMN1; SMN2GJB2SSTR1SSTR2SSTR4
SCHEMBL18483745 1.00 SMN1; SMN2 (0.41) SMN1; SMN2GJB2SSTR1SSTR2SSTR4
SCHEMBL10134736 1.00 SMN1; SMN2 (0.41) SMN1; SMN2GJB2SSTR1SSTR2SSTR4
SCHEMBL12000785 0.98 SMN1; SMN2 (0.42) SMN1; SMN2GJB2SSTR1SSTR2SSTR4
SCHEMBL15255431 0.91 SSTR1 (0.42) SMN1; SMN2GJB2SSTR1SSTR2SSTR4
SCHEMBL12000748 0.90 SMN1; SMN2 (0.39) SMN1; SMN2GJB2SSTR1SSTR2SSTR4
SCHEMBL12580875 0.87 GBA1 (0.33) SMN1; SMN2GJB2GBA1FGF1FGF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012165914-A2 NOVEL DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS GREEN CROSS CORPORATION (KR) 2012-12-06 — — WO disclosed
WO-2012033390-A2 NOVEL THIOPHENE DERIVATIVE AS SGLT2 INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME GREEN CROSS CORPORATION (KR) 2012-03-15 — — WO disclosed
Send feedback